MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
313.05%
Quick Ratio
313.05%
Cash Ratio
62.47%
Debt to Asset Ratio
82.22%
Unit: Thousand (K) dollars
Assets Breakdown
    • Intangible assets, net
    • Accounts receivable, net
    • Cash and cash equivalents
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Convertible debt
    • Others

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
78,362 93,035 110,930 75,154
Marketable debt securities, at fair value
186,314 229,761 143,600 244,383
Accounts receivable, net
87,302 80,134 82,984 38,718
Inventory
6,356 5,875 5,548 4,090
Prepaid expenses and other current assets
34,347 28,760 28,048 17,222
Total current assets
392,681 437,565 371,110 379,567
Long-term inventory
30,698 30,280 31,999 33,590
Property and equipment, net
3,627 4,022 4,320 4,561
Operating lease right of use assets
9,668 10,576 11,464 12,336
Intangible assets, net
110,038 113,868 109,435 105,607
Other assets
8,476 8,880 10,253 19,648
Total assets
555,188 605,191 538,581 555,309
Convertible debt, current portion
NaN 0 0 68,838
Accounts payable
12,912 24,800 18,225 19,134
Accrued expenses
104,408 126,035 105,762 81,682
Operating lease liabilities, current portion
6,017 5,875 5,734 5,595
Other current liabilities
2,100 3,194 5,353 14,291
Total current liabilities
125,437 159,904 135,074 189,540
Convertible debt, less current portion
NaN 311,724 311,370 311,016
Convertible debt
312,079 NaN NaN NaN
Operating lease liabilities, less current portion
9,566 11,134 12,645 14,124
Other non-current liabilities
9,378 7,601 5,928 7,882
Total liabilities
456,460 490,363 465,017 522,562
Common stock 0.0001 par value 200,000,000 shares authorized 92,403,744, and 90,922,868 issued and outstanding as of march 31, 2026 and december 31, 2025, respectively
9 9 9 9
Additional paid-in capital
1,609,596 1,588,721 1,550,051 1,534,698
Accumulated deficit
-1,509,815 -1,472,713 -1,475,442 -1,501,148
Accumulated other comprehensive loss
-1,062 -1,189 -1,054 -812
Total stockholders' equity
98,728 114,828 73,564 32,747
Total liabilities and stockholders' equity
555,188 605,191 538,581 555,309
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Marketable debtsecurities, at fair value$186,314K Accounts receivable, net$87,302K Cash and cashequivalents$78,362K Prepaid expenses andother current assets$34,347K Inventory$6,356K Total current assets$392,681K Intangible assets, net$110,038K Long-term inventory$30,698K Operating lease right ofuse assets$9,668K Other assets$8,476K Property and equipment,net$3,627K Total assets$555,188K Total liabilities andstockholders' equity$555,188K Total liabilities$456,460K Total stockholders'equity$98,728K Accumulated deficit-$1,509,815K Accumulated othercomprehensive loss-$1,062K Convertible debt$312,079K Total currentliabilities$125,437K Operating leaseliabilities, less current...$9,566K Other non-currentliabilities$9,378K Additional paid-in capital$1,609,596K Common stock 0.0001 parvalue 200,000,000...$9K Accrued expenses$104,408K Accounts payable$12,912K Operating leaseliabilities, current portion$6,017K Other currentliabilities$2,100K

Travere Therapeutics, Inc. (TVTX)

Travere Therapeutics, Inc. (TVTX)